최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Korean journal of microbiology = 미생물학회지, v.50 no.2, 2014년, pp.87 - 94
최은영 (부산대학교 약학대학) , 노진기 (부산대학교 약학대학) , 핫산눌하스니 (부산대학교 약학대학) , 유진욱 (부산대학교 약학대학)
Nitric oxide (NO), which has been recognized as an integral molecule in maintaining homeostasis, plays an important role in host defense against microbes. NO has diverse antimicrobial mechanisms by directly and/or indirectly interacting with microbes. Under the circumstance that there is an urgent n...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
NO 합성효소의 종류는? | NO는 기본적으로 L-arginine을 원료물질로 하여 NO 합성효소(nitric oxide synthase, NOS)에 의해 생성된다. NOS는 eNOS (내피세포 산화질소 합성효소, endothelial NOS), nNOS (신경 산화질소 합성효소, neuronal NOS) 및 iNOS (유도성 산화질소 합성효소, inducible NOS) 세가지가 존재하고, 각 효소에 의해 생성된 NO는 발현, 조절 패턴 및 조직 분포 등이 달라진다(Shin et al., 2007; Saraiva et al. | |
인체의 항상성 유지에 관련된, NO의 역할은 무엇인가? | 최근 NO의 다양한 생리학적 영향이 기존에 알려진 것보다 더 광범위 하다는 것이 밝혀졌다 (Friedman and Friedman, 2009). NO는 혈관내피세포의 탄력유지를 통한 혈압조절(Wennmalm, 1994; Amadeu et al., 2007), 혈소판의 기능 조절(Ignarro et al., 1987; Murad, 2006; Miller and Megson, 2007), 장의 연동운동과 음경발기를 조절하는 신경 전달물질(Ignarro et al., 1987; Murad, 2006; Miller and Megson, 2007) 및 상처치료(Witte and Barbul, 2002) 등의 역할을 하여 인체의 항상성 유지에 깊게 관여되어 있다. 특정농도에서 정상 세포에 영향을 주지 않으면서 암세포 사멸효과도 나타내는 것이 알려져 있다(Wink et al. | |
NO는 무엇을 원료물질로 하여 생성되는가? | NO는 기본적으로 L-arginine을 원료물질로 하여 NO 합성효소(nitric oxide synthase, NOS)에 의해 생성된다. NOS는 eNOS (내피세포 산화질소 합성효소, endothelial NOS), nNOS (신경 산화질소 합성효소, neuronal NOS) 및 iNOS (유도성 산화질소 합성효소, inducible NOS) 세가지가 존재하고, 각 효소에 의해 생성된 NO는 발현, 조절 패턴 및 조직 분포 등이 달라진다(Shin et al. |
Amadeu, T.P., Seabra, A.B., de Oliveira, M.G., and Costa, A.M. 2007. S-nitrosoglutathione-containing hydrogel accelerates rat cutaneous wound repair. J. Eur. Acad. Dermatol. Venereol. 21, 629-637.
Assreuy, J., Cunha, F.Q., Epperlein, M., Noronha-Dutra, A., O'Donnell, C.A., Liew, F.Y., and Moncada, S. 1994. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur. J. Immunol. 24, 672-676.
Beckman, J.S. 1991. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15, 53-59.
Bhide, M. 2006. Nitric oxide delivery from polymeric wound dressings. University of Akron.
Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2, 907-916.
Bogdan, C. 2011. Regulation of lymphocytes by nitric oxide. Suppression and Regulation of Immune Responses, pp. 375-393. Springer.
Bryan, N.S., Rassaf, T., Maloney, R.E., Rodriguez, C.M., Saijo, F., Rodriguez, J.R., and Feelisch, M. 2004. Cellular targets and mechanisms of nitros(yl)ation: An insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA 101, 4308-4313.
Bryk, R., Griffin, P., and Nathan, C. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407, 211-215.
Coates, A.R., Halls, G., and Hu, Y. 2011. Novel classes of antibiotics or more of the same? Br. J. Pharmacol. 163, 184-194.
Coneski, P.N. and Schoenfisch, M.H. 2012. Nitric oxide release: part III. Measurement and reporting. Chem. Soc. Rev. 41, 3753-3758.
De Groote, M.A. and Fang, F.C. 1995. NO inhibitions: antimicrobial properties of nitric oxide. Clin. Infect. Dis. 21, S162-S165.
De Groote, M.A., Granger, D., Xu, Y., Campbell, G., Prince, R., and Fang, F.C. 1995. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc. Natl. Acad. Sci. USA 92, 6399-6403.
de Souza, G.F.P., Yokoyama-Yasunaka, J.K., Seabra, A.B., Miguel, D.C., de Oliveira, M.G., and Uliana, S.R.B. 2006. Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: Implications for the treatment of cutaneous leishmaniasis. Nitric Oxide 15, 209-216.
Dukelow, A.M., Weicker, S., Karachi, T.A., Razavi, H.M., McCormack, D.G., Joseph, M.G., and Mehta, S. 2002. Effects of nebulized diethylenetetraamine-NONOate in a mouse model of acute Pseudomonas aeruginosa pneumonia. Chest 122, 2127-2136.
Dusse, L.M.S.A., Vieira, L.M., and Carvalho, M.d.G. 2003. Nitric oxide revision. Brazil. J. Arch. Pathol. Lab. Med. 39, 343-350.
Eiserich, J.P., Hristova, M., Cross, C.E., Jones, A.D., Freeman, B.A., Halliwell, B., and van der Vliet, A. 1998. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391, 393-397.
Englander, L. and Friedman, A. 2010. Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection. J. Clin. Aesthet. Dermatol. 3, 45-50.
Espey, M.G., Miranda, K.M., Thomas, D.D., and Wink, D.A. 2001. Distinction between nitrosating mechanisms within human cells and aqueous solution. J. Biol. Chem. 276, 30085-30091.
Espey, M.G., Miranda, K.M., Thomas, D.D., Xavier, S., Citrin, D., Vitek, M.P., and Wink, D.A. 2002. A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann. Ny. Acad. Sci. 962, 195-206.
Falagas, M.E. and Bliziotis, I.A. 2007. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int. J. Antimicrob. Agents 29, 630-636.
Fang, F.C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99, 2818-2825.
Fernandes, P.D. and Assreuy, J. 1997. Role of nitric oxide and superoxide in Giardia lamblia killing. Braz. J. Med. Biol. Res. 30, 93-99.
Friedman, A. and Friedman, J. 2009. New biomaterials for the sustained release of nitric oxide: past, present and future. Expert Opin. Drug Deliv. 6, 1113-1122.
Ghaffari, A., Jalili, R., Ghaffari, M., Miller, C., and Ghahary, A. 2007. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen. 15, 368-377.
Ghaffari, A., Miller, C.C., McMullin, B., and Ghahary, A. 2006. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 14, 21-29.
Ghaffari, A., Neil, D.H., Ardakani, A., Road, J., Ghahary, A., and Miller, C.C. 2005. A direct nitric oxide gas delivery system for bacterial and mammalian cell cultures. Nitric Oxide 12, 129-140.
Gorham, F. and Scamman, C. 1934. Papers of Charles V. Chapin. MD New York, Commonwealth Fund.
Halpenny, G.M., Gandhi, K.R., and Mascharak, P.K. 2010. Eradication of pathogenic bacteria by remote delivery of NO via light triggering of nitrosyl-containing materials. Acs Med. Chem. Lett. 1, 180-183.
Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., and Chaudhuri, G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric-oxide. Proc. Natl. Acad. Sci. USA 84, 9265-9269.
Ishima, Y., Sawa, T., Kragh-Hansen, U., Miyamoto, Y., Matsushita, S., Akaike, T., and Otagiri, M. 2007. S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial and cytoprotective properties. J. Pharmacol. Exp. Ther. 320, 969-977.
Jo, Y.S., van der Vlies, A.J., Gantz, J., Thacher, T.N., Antonijevic, S., Cavadini, S., Demurtas, D., Stergiopulos, N., and Hubbell, J.A. 2009. Micelles for delivery of nitric oxide. J. Am. Chem. Soc. 131, 14413-14418.
Juedes, M.J. and Wogan, G.N. 1996. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res. 349, 51-61.
Kapadia, M.R., Chow, L.W., Tsihlis, N.D., Ahanchi, S.S., Eng, J.W., Murar, J., Martinez, J., Popowich, D.A., Jiang, Q., Hrabie, J.A., and et al. 2008. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J. Vasc. Surg. 47, 173-182.
Kaplan, S.S., Lancaster, J.R., Jr., Basford, R.E., and Simmons, R.L. 1996. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect. Immun. 64, 69-76.
Karupiah, G. and Harris, N. 1995. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J. Exp. Med. 181, 2171-2179.
Keefer, L.K. 2005. Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): Emerging commercial opportunities. Curr. Top. Med. Chem. 5, 625-634.
Konter, J., Mollmann, U., and Lehmann, J. 2008. NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds. Bioorg. Med. Chem. 16, 8294-8300.
Laval, F., Wink, D., and Laval, J. 1997. A discussion of mechanisms of NO genotoxicty: Implication of inhibition of DNA repair proteins. Rev. Physiol. Biochem. Pharmacol. 131, 175-191.
Laval, F. and Wink, D.A. 1994. Inhibition by nitric oxide of the repair protein, O6-DNA-methyltransferase. Carcinogenesis 15, 443-447.
Laver, J.R., Stevanin, T.M., Messenger, S.L., Lunn, A.D., Lee, M.E., Moir, J.W., Poole, R.K., and Read, R.C. 2010. Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis. FASEB J. 24, 286-295.
Lepoivre, M., Chenais, B., Yapo, A., Lemaire, G., Thelander, L., and Tenu, J.P. 1990. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265, 14143-14149.
Lepoivre, M., Flaman, J.M., and Henry, Y. 1992. Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J. Biol. Chem. 267, 22994-23000.
MacMicking, J., Xie, Q.W., and Nathan, C. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
Maragos, C.M., Andrews, A., Keefer, L.K., and Elespuru, R.K. 1993. Mutagenicity of glyceryl trinitrate (nitroglycerin) in Salmonella typhimurium. Mutat. Res. 298, 187-195.
Marcinkiewicz, J. 1997. Nitric oxide and antimicrobial activity of reactive oxygen intermediates. Immunopharmacology 37, 35-41.
McElhaney-Feser, G.E., Raulli, R.E., and Cihlar, R.L. 1998. Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob. Agents. Chemother. 42, 2342-2346.
Melkova, Z. and Esteban, M. 1995. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155, 5711-5718.
Miller, M.R. and Megson, I.L. 2007. Recent developments in nitric oxide donor drugs. Br. J. Pharmacol. 151, 305-321.
Murad, F. 2006. Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N. Engl. J. Med. 355, 2003-2011.
Nablo, B.J., Rothrock, A.R., and Schoenfisch, M.H. 2005. Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants. Biomaterials 26, 917-924.
Nablo, B.J. and Schoenfisch, M.H. 2005. In vitro cytotoxicity of nitric oxide-releasing sol-gel derived materials. Biomaterials 26, 4405-4415.
Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnok, J.S., and Tannenbaum, S.R. 1992. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89, 3030-3034.
Outterson, K., Samora, J.B., and Keller-Cuda, K. 2007. Will longer antimicrobial patents improve global public health? Lancet Infect. Dis. 7, 559-566.
Pacelli, R., Wink, D.A., Cook, J.A., Krishna, M.C., DeGraff, W., Friedman, N., Tsokos, M., Samuni, A., and Mitchell, J.B. 1995. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med. 182, 1469-1479.
Privett, B.J., Broadnax, A.D., Bauman, S.J., Riccio, D.A., and Schoenfisch, M.H. 2012. Examination of bacterial resistance to exogenous nitric oxide. Nitric Oxide 26, 169-173.
Pryor, W.A., Church, D.F., Govindan, C.K., and Crank, G. 1982. Oxidation of thiols by nitric-oxide and nitrogen-dioxide - synthetic utility and toxicological implications. J. Org. Chem. 47, 156-159.
Raulli, R., McElhaney-Feser, G., Hrabie, J., and Cihlar, R. 2002. Antimicrobial properties of nitric oxide using diazeniumdiolates as the nitric oxide donor. Rec. Res. Devel. Microbiol. 6, 177-183.
Riccio, D.A., Dobmeier, K.P., Hetrick, E.M., Privett, B.J., Paul, H.S., and Schoenfisch, M.H. 2009. Nitric oxide-releasing S-nitrosothiol-modified xerogels. Biomaterials 30, 4494-4502.
Rubbo, H., Radi, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., Kirk, M., and Freeman, B.A. 1994. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269, 26066-26075.
Saraiva, J., Marotta-Oliveira, S.S., Cicillini, S.A., Eloy Jde, O., and Marchetti, J.M. 2011. Nanocarriers for nitric oxide delivery. J. Drug. Deliv. 2011, 936438.
Scatena, R., Bottoni, P., Pontoglio, A., and Giardina, B. 2010. Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. Curr. Med. Chem. 17, 61-73.
Seabra, A.B. and Duran, N. 2010. Nitric oxide-releasing vehicles for biomedical applications. J Mater. Chem. 20, 1624-1637.
Seabra, A.B., Martins, D., Simoes, M.M., da Silva, R., Brocchi, M., and de Oliveira, M.G. 2010. Antibacterial nitric oxide-releasing polyester for the coating of blood-contacting artificial materials. Artif. Organs. 34, E204-214.
Seabra, A.B., Pankotai, E., Feher, M., Somlai, A., Kiss, L., Biro, L., Szabo, C., Kollai, M., de Oliveira, M.G., and Lacza, Z. 2007. S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats. Br. J. Dermatol. 156, 814-818.
Shin, J.H., Metzger, S.K., and Schoenfisch, M.H. 2007. Synthesis of nitric oxide-releasing silica nanoparticles. J. Am. Chem. Soc. 129, 4612-4619.
Singh, R.J., Hogg, N., Joseph, J., and Kalyanaraman, B. 1996. Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271, 18596-18603.
Souza-Lima Sr, R.A., Cariello, A.J., Bispo Sr, M., De Souza Sr, G., De Oliveira, M., Hofling-Lima, A.L., and Pignatari, A. 2011. Bactericidal effect of nitric oxide donors against clinical isolates from keratitis. Invest. Ophtalmol. Vis. Sci. 52, 5839.
Spellberg, B., Powers, J.H., Brass, E.P., Miller, L.G., and Edwards, J.E., Jr. 2004. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38, 1279-1286.
Stadler, J., Trockfeld, J., Schmalix, W.A., Brill, T., Siewert, J.R., Greim, H., and Doehmer, J. 1994. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. USA 91, 3559-3563.
Thomas, D.D., Ridnour, L.A., Isenberg, J.S., Flores-Santana, W., Switzer, C.H., Donzelli, S., Hussain, P., Vecoli, C., Paolocci, N., Ambs, S., and et al. 2008. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic. Biol. Med. 45, 18-31.
Wang, J., Teng, Y.H., Hao, Y., Oh-Lee, J., and Mohanty, D.K. 2009. Preparation and properties of polyamines: part II-controlled and sustained release of nitric oxide (NO) from nitrosated polymers. Polym. J. 41, 715-725.
Wang, P.G., Xian, M., Tang, X., Wu, X., Wen, Z., Cai, T., and Janczuk, A.J. 2002. Nitric oxide donors: chemical activities and biological applications. Chem. Rev. 102, 1091-1134.
Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.P., Xu, D., Muller, W., Moncada, S., and Liew, F.Y. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
Wennmalm, A. 1994. Endothelial nitric oxide and cardiovascular disease. J. Intern. Med. 235, 317-327.
Wink, D.A. and Mitchell, J.B. 1998. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25, 434-456.
Wink, D.A., Nims, R.W., Darbyshire, J.F., Christodoulou, D., Hanbauer, I., Cox, G.W., Laval, F., Laval, J., and Cook, J.A. 1994. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem. Res. Toxicol. 7, 519-525.
Wink, D.A., Osawa, Y., Darbyshire, J.F., Jones, C.R., Eshenaur, S.C., and Nims, R.W. 1993. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300, 115 -123.
Wink, D.A., Ridnour, L.A., Hussain, S.P., and Harris, C.C. 2008. The reemergence of nitric oxide and cancer. Nitric Oxide 19, 65-67.
Witte, M.B. and Barbul, A. 2002. Role of nitric oxide in wound repair. Am. J. Surg. 183, 406-412.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.